Beyond LDL: What Role for PCSK9 in Triglyceride-Rich Lipoprotein Metabolism? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Trends in endocrinology and metabolism: TEM Année : 2018

Beyond LDL: What Role for PCSK9 in Triglyceride-Rich Lipoprotein Metabolism?

Résumé

Elevated plasma triglyceride (TG) levels are an independent risk factor for cardiovascular disease (CVD). Proprotein convertase subtilisin-kexin 9 (PCSK9) - a protein therapeutically targeted to lower plasma cholesterol levels - might regulate plasma TG-rich lipoprotein (TRL) levels. We provide a timely and critical review of the current evidence for a role of PCSK9 in TRL metabolism by assessing the impact of PCSK9 gene variants, by reviewing recent clinical data with PCSK9 inhibitors, and by describing the potential mechanisms by which PCSK9 might regulate TRL metabolism. We conclude that the impact of PCSK9 on TRL metabolism is relatively modest, especially compared to its impact on cholesterol metabolism.
Fichier non déposé

Dates et versions

hal-01833913 , version 1 (24-07-2018)

Identifiants

Citer

Wieneke Dijk, Cédric Le May, Bertrand Cariou. Beyond LDL: What Role for PCSK9 in Triglyceride-Rich Lipoprotein Metabolism?. Trends in endocrinology and metabolism: TEM, 2018, Equipe IV, 29 (6), pp.420 - 434. ⟨10.1016/j.tem.2018.03.013⟩. ⟨hal-01833913⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More